About this event

  • Date and time Mon 16 Nov 2020 from 8:00am to 5:00pm
  • Location Royal Society of Medicine
  • Organised by Oncology

This unique meeting brings together healthcare professionals interested in global oncology to share experiences and increase awareness of topical issues.

Attendees can expect to understand:

• The global disparities in cancer care and how to address this through collaborative networks
• Innovations through digital and other technology, which will improve cancer control in low and middle income settings
• The global movement to eliminate cervical cancer, which could be the most significant achievement of our generation
• How current research in global oncology is improving cancer outcomes
• The role of training programmes in improving human capacity to control cancer in low and middle income settings

CALL FOR ABSTRACTS: Vanessa Moss annual prize

Prizes:

  • Winner of best abstract - £250 and invited for oral presentation
  • Top 10 abstracts – poster presentation

Submission deadline: 28 June 2020

Open to:

  • Any scientist or healthcare professional working in the field of global cancer control may apply
  • Collaborative research / service delivery in which the applicant has been significantly involved, in global cancer control, focusing on LMICs (as defined by World Bank group)
  • Work may have been published previously (but not before 2018)

Abstract guidelines:

Candidates are invited to submit a clinical or research abstract of no more than 400 words, including background, methods, results and discussion. Submissions open to HICs and LMICs. Judging panel will include oncologists and experts in the field of global cancer care who will consider the originality and the impact of the research on the quality of care for patients with cancer in LMICs, within the context of the resources available to the host institution.

The winner must agree to attend the conference. Standard travel expenses will covered by the RSM Oncology Section.

To submit your abstract, click here

Key speakers

Dr Ophira Ginsburg

Dr Ophira Ginsburg

Director Perlmutter Cancer Center High Risk Program, New York University, New York, US

Speaker's biography

Dr Ophira Ginsburg is a medical oncologist and global women’s health researcher with technical and policy expertise in noncommunicable diseases prevention and management.  She is the director of the high-risk cancer genetics program and associate professor in the section for global health, department of population health at New York University School of Medicine. Formerly based at the University of Toronto, from 2015 to 2016 she was a medical officer at WHO and continues to serve as a consultant to several UN agencies, providing technical assistance to member states on national cancer control planning and policies.

Over the last 15 years, Dr Ophira Ginsburg developed an inter-disciplinary collaborative program of research, education, and policy guidance in cancer control, with colleagues on five continents. The overarching aim of her work is to improve equitable access to early detection for breast and cervical cancer in low-income and middle-income countries. She also conducts public health research to reduce cancer disparities for women in underserved communities in North America, and is leading a new study funded by the U.S. National Institutes of Health (“Cancer Moonshot” program), to improve access to cancer genetics services through primary care clinics in the New York area.

Professor Richard Sullivan

Professor Richard Sullivan

Chair, Cancer and Global Health, King’s College London and Guy's and St Thomas' NHS Foundation Trust

Speaker's biography

Professor Richard Sullivan is professor of cancer and global health at King’s College London, and director of the King’s Institute of Cancer Policy and co-director of the Conflict and Health Research Group. As well as holding a number of visiting chairs, Professor Richard Sullivan is an non-communicable disease (NCD) advisor to the World Health Organization (WHO), civil-military advisor to Save the Children, and a member of the National Cancer Grid of India.

His research focuses on global cancer policy and planning, and health systems strengthening, particularly fragile and conflict settings. Professor Richard Sullivan’s research teams have programs in capacity building in conflict and health across the Middle East and North Africa (r4hc-mena.org), as well as programmes in women’s health, digital innovation (VR enhanced surgery) and a wide range of global health security projects. Professor Sullivan qualified in medicine and trained in surgery (urology), gaining his PhD in biochemistry from University College London. As well as working as research and development lead in industry he was also clinical director of Cancer Research UK, one of the world’s largest research funders between 1999 and 2008.

Professor Shailesh V. Shrikhande

Deputy Director and Head of Cancer Surgery, Tata Memorial Centre, Mumbai, India

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Man searching computer

Join the RSM and get unlimited digital learning and e-resources access

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy unlimited digital learning any time you need and access to e-journals, e-books and 7 huge medical databases to support your clinical decision-making and research.

Our e-resources are updated continuously to ensure you receive the cutting edge knowledge you need. 

 

Become a member